164 related articles for article (PubMed ID: 23686431)
41. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W
Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
[TBL] [Abstract][Full Text] [Related]
42. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
43. Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins.
Huang Y; Du Q; Wu W; She F; Chen Y
Mol Med Rep; 2016 Sep; 14(3):2573-81. PubMed ID: 27430608
[TBL] [Abstract][Full Text] [Related]
44. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J
Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445
[TBL] [Abstract][Full Text] [Related]
45. Coexpression of SFRP1 and WIF1 as a prognostic predictor of favorable outcomes in patients with colorectal carcinoma.
Huang S; Zhong X; Gao J; Song R; Wu H; Zi S; Yang S; Du P; Cui L; Yang C; Li Z
Biomed Res Int; 2014; 2014():256723. PubMed ID: 24949429
[TBL] [Abstract][Full Text] [Related]
46. CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.
Tam KW; Zhang W; Soh J; Stastny V; Chen M; Sun H; Thu K; Rios JJ; Yang C; Marconett CN; Selamat SA; Laird-Offringa IA; Taguchi A; Hanash S; Shames D; Ma X; Zhang MQ; Lam WL; Gazdar A
J Thorac Oncol; 2013 Nov; 8(11):1378-88. PubMed ID: 24077454
[TBL] [Abstract][Full Text] [Related]
47. Omega-3 PUFA Alters the Expression Level but Not the Methylation Pattern of the WIF1 Gene Promoter in a Pancreatic Cancer Cell Line (MIA PaCa-2).
Rahmani B; Hamedi Asl D; Naserpour Farivar T; Azad M; Sahmani M; Gheibi N
Biochem Genet; 2019 Aug; 57(4):477-486. PubMed ID: 30649640
[TBL] [Abstract][Full Text] [Related]
48. A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers.
Drilon A; Sugita H; Sima CS; Zauderer M; Rudin CM; Kris MG; Rusch VW; Azzoli CG
J Thorac Oncol; 2014 Sep; 9(9):1272-7. PubMed ID: 25122424
[TBL] [Abstract][Full Text] [Related]
49. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY
Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
[TBL] [Abstract][Full Text] [Related]
50. HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC.
Tseng RC; Huang WR; Lin SF; Wu PC; Hsu HS; Wang YC
J Cell Mol Med; 2014 Sep; 18(9):1752-61. PubMed ID: 24895061
[TBL] [Abstract][Full Text] [Related]
51. WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.
Yang TM; Leu SW; Li JM; Hung MS; Lin CH; Lin YC; Huang TJ; Tsai YH; Yang CT
J Cancer Res Clin Oncol; 2009 Jul; 135(7):919-24. PubMed ID: 19085002
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.
Huang L; Li MX; Wang L; Li BK; Chen GH; He LR; Xu L; Yuan YF
Tumour Biol; 2011 Feb; 32(1):233-40. PubMed ID: 21052890
[TBL] [Abstract][Full Text] [Related]
53. Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer.
Lai JC; Cheng YW; Chiou HL; Wu MF; Chen CY; Lee H
Int J Cancer; 2005 Dec; 117(6):974-80. PubMed ID: 15986439
[TBL] [Abstract][Full Text] [Related]
54. DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer.
Walter K; Holcomb T; Januario T; Du P; Evangelista M; Kartha N; Iniguez L; Soriano R; Huw L; Stern H; Modrusan Z; Seshagiri S; Hampton GM; Amler LC; Bourgon R; Yauch RL; Shames DS
Clin Cancer Res; 2012 Apr; 18(8):2360-73. PubMed ID: 22261801
[TBL] [Abstract][Full Text] [Related]
55. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
Suzuki M; Shigematsu H; Iizasa T; Hiroshima K; Nakatani Y; Minna JD; Gazdar AF; Fujisawa T
Cancer; 2006 May; 106(10):2200-7. PubMed ID: 16598760
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.
Licchesi JD; Westra WH; Hooker CM; Machida EO; Baylin SB; Herman JG
Carcinogenesis; 2008 May; 29(5):895-904. PubMed ID: 18308762
[TBL] [Abstract][Full Text] [Related]
57. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
[TBL] [Abstract][Full Text] [Related]
58. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
[TBL] [Abstract][Full Text] [Related]
59. Genome-wide DNA Methylation Analysis Reveals
Niu X; Liu F; Zhou Y; Zhou Z; Zhou D; Wang T; Li Z; Ye X; Yu Y; Weng X; Zhang H; Ye J; Liao M; Liu Y; Chen Z; Lu S
Clin Cancer Res; 2017 Sep; 23(17):5003-5014. PubMed ID: 28490462
[No Abstract] [Full Text] [Related]
60. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
